🚀 VC round data is live in beta, check it out!
Horiba Valuation Multiples
Discover revenue and EBITDA valuation multiples for Horiba and similar public comparables like Jiangsu Yuyue Medical, Mirion, Teleflex, Sensata Technologies and more.
Horiba Overview
About Horiba
Horiba Ltd provides analytical and measurement equipment. The company operates through five segments. The Automobile segment offers automotive validation, verification technologies, and consulting services. The Environment/Accounting Process segment provides measurement technologies for air, water, and soil quality to support environmental conservation. The Medical segment develops and distributes in vitro diagnostic systems, mainly in the field of hematology. The Science segment delivers high-performance scientific instruments and analytical solutions. The Semiconductor segment specializes in fluid control, measurement, and analysis technologies for researchers, developers, and manufacturers across regions.
Founded
1953
HQ
Employees
9.0K
Website
Financials (LTM)
EV
$5B
Horiba Financials
Horiba reported last 12-month revenue of $2B and EBITDA of $438M.
In the same LTM period, Horiba generated $438M in EBITDA and $247M in net income.
Revenue (LTM)
Horiba P&L
In the most recent fiscal year, Horiba reported revenue of $2B and EBITDA of $393M.
Horiba expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $857M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 43% | XXX | XXX | XXX |
| EBITDA | $438M | XXX | $393M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $247M | XXX | $210M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Horiba Stock Performance
Horiba has current market cap of $6B, and enterprise value of $5B.
Market Cap Evolution
Horiba's stock price is $131.28.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $6B | 0.0% | XXX | XXX | XXX | $5.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHoriba Valuation Multiples
Horiba trades at 2.2x EV/Revenue multiple, and 11.2x EV/EBITDA.
EV / Revenue (LTM)
Horiba Financial Valuation Multiples
As of March 16, 2026, Horiba has market cap of $6B and EV of $5B.
Equity research analysts estimate Horiba's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Horiba has a P/E ratio of 22.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 2.2x | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | 11.2x | XXX | 12.5x | XXX | XXX | XXX |
| EV/EBIT | 13.9x | XXX | 16.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.7x | XXX | XXX | XXX |
| P/E | 22.3x | XXX | 26.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 37.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Horiba Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Horiba Margins & Growth Rates
Horiba's revenue in the last 12 month grew by 2%.
Horiba's revenue per employee in the last FY averaged $0.2M.
Horiba's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Horiba's rule of X is 25% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Horiba Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | 9% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 25% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 7% | XXX | — | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Horiba Public Comps
See public comps and valuation multiples for other Medical Devices and Test & Measurement comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Jiangsu Yuyue Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Mirion | XXX | XXX | XXX | XXX | XXX | XXX |
| Teleflex | XXX | XXX | XXX | XXX | XXX | XXX |
| Sensata Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Asahi Intecc | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Horiba M&A Activity
Horiba acquired XXX companies to date.
Last acquisition by Horiba was on XXXXXXXX, XXXXX. Horiba acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Horiba
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHoriba Investment Activity
Horiba invested in XXX companies to date.
Horiba made its latest investment on XXXXXXXX, XXXXX. Horiba invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Horiba
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Horiba
| When was Horiba founded? | Horiba was founded in 1953. |
| Where is Horiba headquartered? | Horiba is headquartered in Japan. |
| How many employees does Horiba have? | As of today, Horiba has over 9K employees. |
| Who is the CEO of Horiba? | Horiba's CEO is Atsushi Horiba. |
| Is Horiba publicly listed? | Yes, Horiba is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Horiba? | Horiba trades under 6856 ticker. |
| When did Horiba go public? | Horiba went public in 1974. |
| Who are competitors of Horiba? | Horiba main competitors are Jiangsu Yuyue Medical, Mirion, Teleflex, Sensata Technologies. |
| What is the current market cap of Horiba? | Horiba's current market cap is $6B. |
| What is the current revenue of Horiba? | Horiba's last 12 months revenue is $2B. |
| What is the current revenue growth of Horiba? | Horiba revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Horiba? | Current revenue multiple of Horiba is 2.2x. |
| Is Horiba profitable? | Yes, Horiba is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Horiba? | Horiba's last 12 months EBITDA is $438M. |
| What is Horiba's EBITDA margin? | Horiba's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Horiba? | Current EBITDA multiple of Horiba is 11.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.